hutch-med.com (HCM): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo grafis HUTCHMED Ltd (HCM)

HUTCHMED (China) Limited (HCM) is monetizing its global oncology portfolio, generating multi-year royalties from patents. Tracking the projected change in earnings per share for the coming year on GURU.Markets, we note that the current metric is 27.50. Collaborations with biopharma behemoths to mitigate risks ensure stability. However, threats of approval delays in the US and an active burn of operating capital remain.

Hutchison MediPharma (HCM): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 16.11.2026

Rincian metrik lan analitis perusahaan HUTCHMED Ltd (HCM)

Pambiji fundamental perusahaan:HUTCHMED Ltd
Produk merek Hutchison MediPharma

HUTCHMED (China) Limited's status as an oncology innovator enables the company to scale revenue through international drug recognition, which directly impacts the calculation of expected earnings per share. This metric measures the analysts' consensus forecast for net income growth rates, reflecting cash flow stability and asset revaluation risks, as clearly demonstrated by the projected change in earnings per share for the coming year.

Pesaing langsung

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep nuvationbio.com (NUVB)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Day One Biopharmaceuticals Inc (DAWN)|MNPR - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Inhibrx Biosciences Inc INBX|I-Mab - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FENC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep herontx.com|NVCT: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Coherus CHRS|Prakiraan wutah bathi saben saham kanggo taun ngarep CRBP|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardiff Oncology CRDF|Prakiraan wutah bathi saben saham kanggo taun ngarep BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Lixte Biotechnology - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep CTXR (Citius Pharma)|Cellectar - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BLRX (BioLineRx Corp)|CANF: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea (APRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kaziatherapeutics.com|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)